VeriMomIst lipase in der Schwangerschaft sicher?
No harmonised CLP reproductive classifications or CIR/SCCS safety assessments identify lipase (CAS 9001-62-1) as a reproductive or teratogenic hazard; ECHA lists the substance as an enzyme registration but no H360/H361 harmonised classification is present. However, SCCS data (Vitamin A opinion) show that topical lipase can rapidly metabolise/alter retinyl palmitate and increase cutaneous bioavailability of co-applied retinoids, so the primary concern is indirect (increasing penetration of other active ingredients) rather than intrinsic reproductive toxicity. ([echa.europa.eu](https://echa.europa.eu/substance-information/-/substanceinfo/100.029.642?utm_source=openai))
Pregnancy-safe products containing lipase
Related ingredients
Frequently asked questions
- Ist lipase in der Schwangerschaft sicher?
- No harmonised CLP reproductive classifications or CIR/SCCS safety assessments identify lipase (CAS 9001-62-1) as a reproductive or teratogenic hazard; ECHA lists the substance as an enzyme registration but no H360/H361 harmonised classification is present. However, SCCS data (Vitamin A opinion) show that topical lipase can rapidly metabolise/alter retinyl palmitate and increase cutaneous bioavailability of co-applied retinoids, so the primary concern is indirect (increasing penetration of other active ingredients) rather than intrinsic reproductive toxicity. ([echa.europa.eu](https://echa.europa.eu/substance-information/-/substanceinfo/100.029.642?utm_source=openai))
- Ist lipase während des Stillens sicher?
- No evidence that lipase itself causes reproductive or lactation-related toxicity or that it is a known human teratogen. Dermally applied enzyme preparations are large protein molecules with negligible systemic absorption in normal cosmetic use, so direct exposure to breastfed infants is unlikely; the main mechanism-based concern is again indirect — lipase can alter penetration/metabolism of co-formulated actives (e.g., retinoids) which are of concern in pregnancy/lactation. No data were found showing lipase partitions into breastmilk or exerts direct effects on lactation. ([echa.europa.eu](https://echa.europa.eu/substance-information/-/substanceinfo/100.029.642?utm_source=openai))
- Ist lipase sicher für Babyhaut?
- There is no evidence that lipase is a reproductive toxicant for infants. For baby (0–3 yr) skin, absorption/exposure scoring is increased by +1 per your rules because infant skin has a less mature barrier and higher surface-area-to-weight — while lipase is a large enzyme with generally low dermal absorption, infant exposure is plausibly higher than adult. The same indirect-mechanism caveat applies: lipase can metabolise or increase penetration of co-applied actives (SCCS Vitamin A data). No infant-specific toxicity data were identified. ([cirs-group.com](https://www.cirs-group.com/files/bjaxyplqmqyo/content/2022/11/c2965g2xf4zk.pdf?utm_source=openai))
- Wie bewertet VeriMom lipase?
- VeriMom bewertet lipase mit 93/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu lipase?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu lipase basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.